BNP Paribas Asset Management Holding S.A. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 26 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
BNP Paribas Asset Management Holding S.A. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,991
+2.4%
2,000,0000.0%0.01%0.0%
Q4 2022$1,944
-99.9%
2,000,0000.0%0.01%
-12.5%
Q3 2022$1,940,000
-0.3%
2,000,0000.0%0.01%
+14.3%
Q2 2022$1,946,000
-0.5%
2,000,0000.0%0.01%0.0%
Q1 2022$1,955,000
-2.5%
2,000,0000.0%0.01%0.0%
Q4 2021$2,006,000
+0.5%
2,000,0000.0%0.01%0.0%
Q3 2021$1,997,000
+1.2%
2,000,0000.0%0.01%0.0%
Q2 2021$1,973,000
-4.1%
2,000,0000.0%0.01%
-12.5%
Q1 2021$2,057,000
+8.7%
2,000,0000.0%0.01%
-11.1%
Q4 2020$1,893,000
+3.8%
2,000,0000.0%0.01%
-10.0%
Q3 2020$1,823,000
+4.5%
2,000,0000.0%0.01%
-16.7%
Q2 2020$1,745,000
+5.1%
2,000,0000.0%0.01%
-14.3%
Q1 2020$1,661,000
-3.7%
2,000,0000.0%0.01%
+16.7%
Q4 2019$1,725,000
+3.9%
2,000,0000.0%0.01%
-7.7%
Q3 2019$1,661,000
-73.5%
2,000,000
-72.7%
0.01%
-74.5%
Q2 2019$6,278,0007,330,0000.05%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$39,863,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,837,0001.32%
Penn Mutual Asset Management 810$806,0000.86%
WOLVERINE ASSET MANAGEMENT LLC 47,643,000$47,931,0000.45%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,750,0000.25%
OAKTREE CAPITAL MANAGEMENT LP 18,672,000$18,683,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 9,833,000$9,883,0000.20%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,956,0000.15%
SSI INVESTMENT MANAGEMENT LLC 2,500,000$2,490,0000.15%
AVIVA PLC 31,500,000$31,724,0000.13%
View complete list of LIGAND PHARMACEUTICALS INC shareholders